Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Mitchell Total Loss Data: Q3 2017
The chart below illustrates the total loss data for both vehicle age and actual cash value of total loss vehicles processed through Mitchell server
Mitchell
Article
Mitchell Canadian Collision Summary: Q3 2017
Canadian Appraisal Severity Average Appraisal Values Severity Overall The average gross initial appraisal value, calculated by
Mitchell
Conference
NACE Automechanika 2018
With hundreds of exhibiting companies and thousands of attendees,
Workers' Comp
Blog
Are You Thankful for Workers’ Comp?
While we gather around the table on Thursday, many of us will give thanks for the blessings in our lives. Will workers’ comp be among them?
Workers' Comp
Article
California Senate Bill 1160: New Utilization Review Regulations Take Effect January 1, 2018
With an effective date of January 1, 2018 for California Senate Bill (SB) 1160 rapidly closing in, many stakeholders in our industry are continuing
Auto Casualty
Article
CPT Code Changes for 2018: Things to Look Out For
A new year means new Current Procedural Terminology (CPT) code changes!